Resultados da busca - Segundo Mariz

Regulatory Standards in Orphan Medicinal Product Designation in the EU por Stelios Tsigkos, Segundo Mariz, Maria Elzbieta Sheean, Kristina Larsson, Armando Magrelli, Armando Magrelli, Violeta Stoyanova-Beninska, Violeta Stoyanova-Beninska

Obter o texto integral

Advanced Therapy Medicinal Products for Rare Diseases: State of Play of Incentives Supporting Development in Europe por Andreas M. Farkas, Segundo Mariz, Violeta Stoyanova-Beninska, Violeta Stoyanova-Beninska, Patrick Celis, Spiros Vamvakas, Kristina Larsson, Bruno Sepodes, Bruno Sepodes

Obter o texto integral

Orphan Medicinal Products for the Treatment of Pancreatic Cancer: Lessons Learned From Two Decades of Orphan Designation por Jorn Mulder, Tobias van Rossum, Segundo Mariz, Armando Magrelli, Anthonius de Boer, Anthonius de Boer, Anna M. G. Pasmooij, Violeta Stoyanova-Beninska

Obter o texto integral

Defining Satisfactory Methods of Treatment in Rare Diseases When Evaluating Significant Benefit–The EU Regulator's Perspective por Maria E. Sheean, Frauke Naumann-Winter, Frauke Naumann-Winter, Giuseppe Capovilla, Giuseppe Capovilla, Giuseppe Capovilla, Maria Elisabeth Kalland, Maria Elisabeth Kalland, Eva Malikova, Eva Malikova, Eva Malikova, Segundo Mariz, Darius Matusevicius, Darius Matusevicius, Robert Nistico, Robert Nistico, Brigitte Schwarzer-Daum, Brigitte Schwarzer-Daum, Stelios Tsigkos, Kyriaki Tzogani, Kristina Larsson, Armando Magrelli, Armando Magrelli, Violeta Stoyanova-Beninska, Violeta Stoyanova-Beninska

Obter o texto integral